Financials

%ChgLast 12MReverse

	FY202312/31/2023	FY202412/31/2024	FY202512/31/2025	Last 12M06/30/2026
Cash and Cash Equivalents	251.9	144.2	516.5	388.0
Short Term Investments	9.1	-	13.7	22.7
Cash and Short Term Investments	261.0	144.2	530.2	410.7
Net Receivables	19.1	15.7	10.5	12.4
Inventory	-	-	-	-
Other Current Assets	-0.0	-	-	0.1
Total Current Assets	286.0	170.7	551.0	427.6
Property, Plant & Equipment	0.9	2.7	2.1	1.5
Long Term Investments	0.1	0.1	-	-
Other Non-Current Assets	15.1	6.7	6.0	8.0
Total Non-Current Assets	41.1	34.6	33.1	34.6
Total Assets	327.1	205.2	584.1	462.2
Account Payables	47.2	43.8	37.6	18.3
Short Term Debt	30.9	42.8	1.3	-
Deferred Revenue	0.1	-	-	-
Other Current Liabilities	3.5	0.5	11.3	28.6
Total Current Liabilities	88.1	92.8	63.0	71.7
Long Term Debt	26.6	52.2	30.2	-
Other Non-Current Liabilities	16.2	18.2	29.5	24.1
Total Non-Current Liabilities	42.9	71.8	66.1	24.3
Total Liabilities	131.1	164.6	129.1	95.9
Common Stock	0.6	0.6	0.8	0.8
Retained Earnings	-282.9	-438.9	-738.2	-865.0
Total Stockholders Equity	196.0	40.6	455.0	366.3
Total Liabilities and Equity	327.1	205.2	584.1	462.2

Abivax S.A. American Depositary Receipt(ABVX US)